To further investigate the significance of α-enolase and MBP-1 expression in breast cancer, we firstly analyzed protein expression in a series of patients with IDC using a commercially available tumor tissue array (TMA) and the ENO-19/8 monoclonal antibody. This evidence concerns the gene ENO1 and breast carcinoma.